Abstract
The BioCD is a spinning-disc interferometric biosensor on which antibodies are immobilized to capture target antigens from biological samples. In this work, BioCDs measured the interferometric response to prostate-specific antigen (PSA). The ideal detection limit for PSA was determined using a BioCD with 12,500 printed target antibody spots with a corresponding number of reference protein spots. Statistical analysis projects the detection limit of PSA as a function of the number of spots included in the average. When approximately 10,000 spot pairs were averaged, the 3σ detection limit was 60 pg/ml in a 2 mg/ml simple protein background. A standard format for BioCD immunoassays uses 96 wells with 32 target spots paired with reference spots. In serum, the detection limit for this format was 1 ng/ml in 3:1 diluted female human serum using a sandwich assay with a nonfluorescent mass tag.
Similar content being viewed by others
References
Bueso-Ramos C, Xu YL, McDonnell TJ, Brisbay S, Pierce S, Kantarjian H, Rosner G, Garcia-Manero G (2005) J Clin Oncol 23:3932–3939
Ozen H, Sozen S (2006) Eur Urol Suppl 5:495–499
Wang MC, Papsidore LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM (1981) Prostate 2:89–96
Lovgren J, Valtonen-Andre C, Marsal K, Lilja H, Lundwall A (1999) J Androl 20:348–355
Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, Dekernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, Macfarlane MT, Southwick PC (1994) J Urololgy 151:1283–1290
Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA (1989) Am J Clin Pathol 92:760–764
Bostwick DG (1994) Am J Clin Pathol 102:S31–S37
Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA (2004) New Engl J Med 350:2239–2246
Herschman JD, Smith DS, Catalona WJ (1997) Urology 50:239–243
Crawford ED, Schutz MJ, Clejan S, Drago J, Resnick MI, Chodak GW, Gomella LG, Austenfeld M, Stone NN, Miles BJ, Thomson R (1992) JAMA 267:2227–2228
Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong ENP, Parson RE, Gasior GH, Loveland KG, Southwick PC (1998) JAMA 279:1542–1547
Dyson J (1957) J Opt Soc Am 47:386–390
Zhao M, Wang X, Nolte D (2007) Proc SPIE 6447:64470B
Johnson B, Löfas S, Lindquist G (1991) Anal Chem 198:268–277
Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlssson R, Lundh K, Lofas S, Persson B, Roos H, Ronnberg I, Sjolander S, Stenberg E, Stahlberg R, Urbaniczky C, Ostilin H, Malmqvist M (1991) BioTechniques 11:620–627
Homola J, Yee S, Gauglitz G (1999) Sens Actuators B Chem 54:3–15
Malmsten M (1994) J Colloid Interface Sci 166:333–342
Landgren M, Jonsson B (1993) J Phys Chem 97:1656–1660
Lousinian S, Logothetidis S (2007) Microelectron Eng 84:479–485
Wang X, Zhao M, Nolte D (2007) Appl Opt 46:7836–7849
Gauglitz G (2005) Anal Bioanal Chem 381:141–155
Belanger A, Vanhalbeek H, Graves HCB, Grandbois K, Stamey TA, Huang LH, Poppe I, Labrie F (1995) Prostate 27:187–197
Acknowledgements
This work was sponsored under grants from Quadraspec Inc. and from the Indiana Economic Development Corporation through the Purdue Research Foundation. We thank Sven Schreiber, Benjamin Edquist, and other staff at Quadraspec Inc. for help in printing the antibody microarray and advice on BioCD surface chemistry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, X., Zhao, M. & Nolte, D.D. Prostate-specific antigen immunoassays on the BioCD. Anal Bioanal Chem 393, 1151–1156 (2009). https://doi.org/10.1007/s00216-008-2370-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2370-8